TOMSK, RUSSIA / RankWire.AI / – Russian researchers have created and evaluated a bioactive layer for titanium orthopedic implants. Utilizing calcium phosphate derived from hydroxyapatite, this coating incorporates nitrogen compounds associated with nitric oxide production. Laboratory experiments demonstrated that human mesenchymal stem cells exhibited higher survival rates on coated titanium surfaces compared to uncoated metal. In addition, the team analyzed surface chemistry, hardness, thickness, and wettability. The peer-reviewed research focused on how varying gas mixtures influenced the coating’s properties and biological responses.
The coatings were produced by scientists at Tomsk Polytechnic University through reactive magnetron sputtering performed within a vacuum chamber. They employed a hydroxyapatite target and modified the nitrogen and argon gas ratios during the deposition process. Five different gas conditions were tested, including pure nitrogen and pure argon, each inducing measurable changes in the coating’s characteristics. The team evaluated surface structure, chemical makeup, mechanical strength, and liquid contact angle. Subsequently, they exposed the coated titanium samples to human mesenchymal stem cells under controlled laboratory conditions.
Results indicated that argon concentration affected several physical attributes of the coating. Higher argon levels produced coatings that were thicker, denser, and harder. Chemical analyses revealed the presence of nitrogen-carbon and nitrogen-oxygen bonds in the modified surfaces. When comparing cell survival rates, the coated samples consistently supported significantly higher cell viability than untreated titanium. The team also examined gene expression related to early bone-cell differentiation to understand how the coatings influenced cellular behavior.
Enhanced cell survival observed on coated titanium surfaces
An increase in nitrogen content was linked to changes in the activity of certain genes involved in early bone-cell differentiation, with effects becoming noticeable after seven days of cell growth. Despite these gene expression modifications, the cells maintained their capacity to produce bone-related tissue. It is important to note that the study did not involve testing in human subjects nor did it evaluate clinical outcomes of medical implants. Consequently, the findings are limited to laboratory performance metrics rather than proven benefits for patients receiving joint replacements or other orthopedic devices.
The biomedical evaluation was carried out by researchers from Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional participation from Saint Petersburg State University in the broader project. The investigation explored how different coating compositions influence both material properties and cellular responses. Hydroxyapatite, chosen for its calcium phosphate structure similar to that of human bone mineral, served as the base material, while nitrogen exposure was varied during the coating process.
Future experiments will focus on long-term biological effects
Following the initial seven-day tests, the research team plans to conduct further laboratory and biological assessments. These will involve monitoring stem cell activity over periods ranging from 10 to 28 days. Researchers also aim to evaluate the dissolution rate of the coatings and track nitric oxide release into surrounding tissues in living organisms. Such experiments were not part of the current published study. At present, the findings are confined to laboratory measurements, coated titanium samples, and controlled cell culture experiments.
This research adds valuable insights into how nitrogen and argon ratios influence calcium phosphate coatings for titanium implants. It documented variations in coating thickness, density, hardness, chemical bonds, and cellular responses. Throughout testing conditions, coated samples demonstrated consistently better support for stem-cell survival compared to untreated titanium. However, the research remains in the preclinical stage and does not establish safety or efficacy for human use. Future studies will explore additional properties, including long-term cell behavior and nitric oxide release, which were not measured in this initial investigation.